search icon

    Market Snapshot

    • S&P Futures

      3,779.5

    • Dow Futures

      30,569

    • Nasdaq Futures

      11,622.75

    blog search icon

    Assembly Biosciences, Inc.

    (NASDAQ:ASMB)

    $2.15

    $-0.04

    -1.60%

    Assembly Biosciences, Inc. Chart

    ASMB Stock Price Today

    Assembly Biosciences, Inc. (ASMB) stock declined over -1.60% intraday to trade at $2.15 a share on NASDAQ. The stock opened with a gain of 2.87% at $2.12 and touched an intraday high of $2.21, rising 2.38% against the last close of $2.1. The stock went to a low of $2.06 during the session.

    Stock Snapshot

    $2.1

    Prev. Close

    101.31 Million

    Market Cap

    $2.06

    Day Low

    $2.12

    Open

    48.12 Million

    Number of Shares

    $2.21

    Day High

    -

    P/E ratio

    -2.78

    EPS (TTM)

    3.05

    Cash Flow per Share

    2.32

    Free Float in %

    4.77

    Book Value

    317,995

    Volume

    Assembly Biosciences, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$2.12$2.21$2.06$2.19218,000
    2022-06-30$2.09$2.15$2.07$2.1234,700
    2022-06-29$2.11$2.17$2.06$2.13276,900
    2022-06-28$2.22$2.22$2.11$2.12188,500
    2022-06-27$2.2$2.24$2.07$2.19352,900
    2022-06-24$2.25$2.27$2.16$2.18519,600
    2022-06-23$2.19$2.28$2.15$2.27415,000
    2022-06-22$2.07$2.17$2.06$2.16289,700
    2022-06-21$2.02$2.2$2.02$2.09939,500
    2022-06-17$2.03$2.17$1.96$2999,900

    Contact Details

    331 Oyster Point Boulevard
    Fourth Floor
    South San Francisco, CA 94080
    United States

    Webiste:ASMB

    833 509 4583

    Company Information

    Employees-

    Beta0.73

    Sales or Revenue6.25 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

    Frequently Asked Questions

    icon

    What is the current Assembly Biosciences, Inc. (ASMB) stock price?

    Assembly Biosciences, Inc. (NASDAQ: ASMB) stock price is $2.15 as of the last check on Friday, July 1. During the trading session, ASMB stock reached the peak price of $2.21 while $2.06 was the lowest point it dropped to.

    icon

    ASMB's industry and sector of operation?

    The NASDAQ listed ASMB is part of Biotechnology industry that operates in the broader Health Care sector. Assembly Biosciences, Inc. , a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States.

    icon

    Who are the executives of ASMB?

    Ms. Lauren Glaser
    Sr. VP of Investor Relations & Corp. Affairs
    Dr. John G. McHutchison A.O., FRACP, M.D.
    CEO, Pres & Director
    Mr. Jason A. Okazaki
    Chief Operating Officer
    Dr. William E. Delaney IV, Ph.D.
    Chief Scientific Officer

    icon

    What is the ASMB stock price today?

    ASMB stock traded closed the last session at $2.19, which is $-0.04 or -1.60% lower than its previous close of $2.1. ASMB's current trading price is 63.27% lower than its 52-week high of $3.94 where as its distance from 52-week low of 1.32% is -45.30%.

    icon

    How many employees does ASMB have?

    Number of ASMB employees currently stands at -. ASMB operates from 331 Oyster Point Boulevard, Fourth Floor, South San Francisco, CA 94080, United States.

    icon

    Link for ASMB official website?

    Official Webiste of $ASMB is: https://www.assemblybio.com

    icon

    How do I contact ASMB?

    ASMB could be contacted at ASMB operates from 331 Oyster Point Boulevard, Fourth Floor, South San Francisco, CA 94080, United States, or at phone #833 509 4583 and can also be accessed through its website.

    icon

    How many shares of ASMB are traded daily?

    ASMB stock volume for the day was 317,995 shares while in the previous session number of ASMB shares traded was 218,000 . The average number of ASMB shares traded daily for last 3 months was 460.63 Thousands.

    icon

    How much did ASMB change today?

    The percentage change in ASMB stock occurred in the recent session was -1.60% while the dollar amount for the price change in ASMB stock was $-0.04.

    icon

    What price range ASMB stock been trading in?

    In the recent session, the day high for ASMB stock was $2.21 while the low for ASMB stock touched on the day was $2.06.

    icon

    What is the market cap of ASMB currently?

    The market value of ASMB currently stands at 101.31 Million with its latest stock price at $2.15 and 48.12 Million of its shares outstanding.